Fu-Chi Yang
Fu-Chi Yang is an expert in Neurology at National Defense Medical Center (Taiwan). Fu-Chi Yang has authored 190 publications, the most recent in 2026. SLR score: 544 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Psychiatry - Public Health - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2008 - 2026
Number : 190
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| 2026 Taiwan guidelines for the acute pharmacologic treatment of migraine in adults. PMID 42723131 — headache, pharmaceutical preparations, migraine disorders, acetaminophen, analgesics, tramadol, therapeutics | J Chin Med Assoc | 2026 | 0 |
| Integrated Transcriptomic and Functional Profiling Reveals IL-7R/FOXO1 Axis as a Target of Momordicine I in Meningioma. PMID 42634359 — cells, cell survival, neoplasms, meningioma, therapeutics, apoptosis, cell cycle | Anticancer Agents Med Chem | 2026 | 0 |
| Case Report: Anti-GABA-B receptor encephalitis with refractory status epilepticus and favorable short-term recovery. PMID 42614298 — serum, neoplasms, multiple chronic conditions, recycling, receptors, gaba-b, plasma exchange, seizures, therapeutics, encephalitis, plasma, status epilepticus | Front Immunol | 2026 | 0 |
| Vagus nerve stimulation for refractory status epilepticus: A systematic review. PMID 42531696 — vagus nerve stimulation, epilepsy, sleep, vagus nerve, seizures, therapeutics, status epilepticus | Seizure | 2026 | 0 |
| Reappraising lithium, triiodothyronine and second-generation antipsychotic augmentation treatment for major depression: a systematic review and meta-analysis with bias-adjustment analyses. PMID 42532626 — depression, aripiprazole, bias, triiodothyronine, antipsychotic agents, therapeutics, mental health | BMJ Ment Health | 2026 | 0 |
LeadR Networks
Main global connection map